NCT05630443 Effects of Prone Position After Major Abdominal Surgery
| NCT ID | NCT05630443 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vastra Gotaland Region |
| Condition | Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2022-10-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2022-10-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluation of postoperative prone position after major abdominal surgery. A randomized clinical trial of 100+100 patients and further add a voice/speech/singing protocol.
Eligibility Criteria
Patients eligable for abdominal surgery aim to cure with: Inclusion Criteria: \- malignancy of the esophagus, gastric- or pancreas Exclusion Criteria: -.not able to understand Swedish in writing or speaking \- preoperatively unable to perform a prone position
Contact & Investigator
Cecilia Engstrom Mattisson, MD PhD
PRINCIPAL INVESTIGATOR
Dept of Surgery, Sahlgrenska University Hospital, Gothenburg University, Sweden
Frequently Asked Questions
Who can join the NCT05630443 clinical trial?
This trial is open to participants of all sexes, studying Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05630443 currently recruiting?
Yes, NCT05630443 is actively recruiting participants. Contact the research team at cecilia.engstrom.@surgery.gu.se for enrollment information.
Where is the NCT05630443 trial being conducted?
This trial is being conducted at Gothenburg, Sweden.
Who is sponsoring the NCT05630443 clinical trial?
NCT05630443 is sponsored by Vastra Gotaland Region. The principal investigator is Cecilia Engstrom Mattisson, MD PhD at Dept of Surgery, Sahlgrenska University Hospital, Gothenburg University, Sweden. The trial plans to enroll 200 participants.